Mankind Pharma Limited is engaged in the manufacturing and marketing of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as consumer healthcare products. The company is primarily focused on the domestic market, which contributed to 97.6% of total revenue from operations for the financial year 2022. It is the fourth-largest pharmaceutical company in India in terms of domestic sales.
Mankind Pharma has a pan-India marketing presence and operates 25 manufacturing facilities across the country. It also has one of the largest distribution networks of medical representatives in the Indian pharmaceutical market.
The entire public offer of Mankind Pharma Limited is an offer for sale of equity shares aggregating up to Rs. Rs. 4,326 crores from existing shareholders.
||Total Assets (₹ crores)
||Total Revenue (₹ crores)
||Profit After Tax (₹ crores)
||EBITDA (₹ crores)
|March 31, 2020
|March 31, 2021
|March 31, 2022
|As of December 31, 2021
|As of December 31, 2022
||25th April to 27th April 2023
|Deadline for accepting UPI mandate
||Until 5 PM on the issue closing day
|Finalization of Allotment
||3rd May 2023
|Initiation of Refunds
||4th May 2023
|Credit of Shares
||8th May 2023
|Date of Listing
||9th May 2023
|Mandate end date
||12th May 2023
|Anchor Investors Lock-In End Date
||27th May 2023
How do I apply to the Mankind Pharma Limited IPO?
You can apply for the Mankind Pharma Limited IPO using any supported UPI app
by following two steps:
- Enter your bid on Kite
- Accept the UPI mandate on your phone
On acceptance of the mandate, the bid amount will get blocked in your bank account. Click here
to learn more.
Where do I check the allotment status for Mankind Pharma Limited IPO?
You can check the allotment status for the Mankind Pharma Limited IPO on the website of the Registrar and Transfer agent
Alternatively, you can also check the allotment status on the NSE website